S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

LHC Group Stock Price, Forecast & Analysis (NASDAQ:LHCG)

$127.64
-0.83 (-0.65 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$126.49
Now: $127.64
$128.64
50-Day Range
$106.93
MA: $115.82
$128.10
52-Week Range
$88.18
Now: $127.64
$136.67
Volume138,400 shs
Average Volume235,292 shs
Market Capitalization$4.02 billion
P/E Ratio35.95
Dividend YieldN/A
Beta0.79
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including skilled nursing, private duty nursing, physical, occupational and speech therapy, medically-oriented social services and hospice care. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:LHCG
CUSIP50187A10
Phone337-233-1307

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.81 billion
Cash Flow$3.84 per share
Book Value$45.40 per share

Profitability

Net Income$63.57 million

Miscellaneous

Employees30,985
Market Cap$4.02 billion
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable

Receive LHCG News and Ratings via Email

Sign-up to receive the latest news and ratings for LHCG and its competitors with MarketBeat's FREE daily newsletter.


LHC Group (NASDAQ:LHCG) Frequently Asked Questions

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) posted its quarterly earnings data on Wednesday, November, 6th. The health services provider reported $1.26 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.08 by $0.18. The health services provider earned $528.50 million during the quarter, compared to the consensus estimate of $534.15 million. LHC Group had a return on equity of 9.39% and a net margin of 4.59%. LHC Group's quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.95 earnings per share. View LHC Group's Earnings History.

When is LHC Group's next earnings date?

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for LHC Group.

What guidance has LHC Group issued on next quarter's earnings?

LHC Group updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share guidance of $4.35-4.45 for the period, compared to the Thomson Reuters consensus estimate of $4.33. The company issued revenue guidance of $2.09-2.14, compared to the consensus revenue estimate of $2.10 billion.

What price target have analysts set for LHCG?

11 analysts have issued twelve-month price objectives for LHC Group's shares. Their forecasts range from $114.00 to $146.00. On average, they anticipate LHC Group's share price to reach $130.80 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for LHC Group.

What is the consensus analysts' recommendation for LHC Group?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

Has LHC Group been receiving favorable news coverage?

Headlines about LHCG stock have been trending very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LHC Group earned a news impact score of -3.2 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for LHC Group.

Are investors shorting LHC Group?

LHC Group saw a drop in short interest in September. As of September 30th, there was short interest totalling 1,860,000 shares, a drop of 7.0% from the August 30th total of 2,000,000 shares. Based on an average daily trading volume, of 220,100 shares, the days-to-cover ratio is presently 8.5 days. Approximately 6.3% of the company's shares are sold short. View LHC Group's Current Options Chain.

Who are some of LHC Group's key competitors?

What other stocks do shareholders of LHC Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Cisco Systems (CSCO), Visa (V), Chevron (CVX), Verizon Communications (VZ), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Exxon Mobil (XOM) and Intel (INTC).

Who are LHC Group's key executives?

LHC Group's management team includes the folowing people:
  • Keith G. Myers, Chairman & Chief Executive Officer
  • Donald Dwayne Stelly, President & Chief Operating Officer
  • Joshua L. Proffitt, Chief Financial Officer & Executive Vice President
  • Angie M. Begnaud, Chief Clinical Officer & Executive Vice President
  • Benjamin Doga, Chief Medical Officer

Who are LHC Group's major shareholders?

LHC Group's stock is owned by many different of retail and institutional investors. Top institutional shareholders include TimesSquare Capital Management LLC (1.84%), GW&K Investment Management LLC (1.11%), Sumitomo Mitsui Trust Holdings Inc. (0.96%), Tributary Capital Management LLC (0.88%), Summit Creek Advisors LLC (0.51%) and Copper Rock Capital Partners LLC (0.48%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

Which major investors are selling LHC Group stock?

LHCG stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Sawgrass Asset Management LLC, First National Bank of Omaha, Tributary Capital Management LLC, Calamos Advisors LLC, Scout Investments Inc., PRW Wealth Management LLC and Chartwell Investment Partners LLC. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.

Which major investors are buying LHC Group stock?

LHCG stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Westwood Management Corp IL, Columbus Circle Investors, GW&K Investment Management LLC, TimesSquare Capital Management LLC, California Public Employees Retirement System, Sumitomo Mitsui Trust Holdings Inc. and State of Alaska Department of Revenue. View Insider Buying and Selling for LHC Group.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $127.64.

How big of a company is LHC Group?

LHC Group has a market capitalization of $4.02 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

What is LHC Group's official website?

The official website for LHC Group is http://www.lhcgroup.com/.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]


MarketBeat Community Rating for LHC Group (NASDAQ LHCG)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  316 (Vote Outperform)
Underperform Votes:  338 (Vote Underperform)
Total Votes:  654
MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote "Outperform" if you believe LHCG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LHCG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel